太安堂3深陷多重危机

Core Viewpoint - Guangdong Tai'an Tang Pharmaceutical Co., Ltd. (Tai'an Tang 3) has reported a significant number of legal disputes, totaling 35 cases with a combined amount of approximately 963.72 million yuan, which represents 2104.12% of the company's latest audited net assets [1] Group 1: Legal Issues - The company and its subsidiaries are involved in 35 legal cases, with the majority (approximately 919.98 million yuan) as defendants or respondents [1] - A notable case includes a securities false statement liability dispute that has already been heard by the Shantou Intermediate People's Court [1] - The company has received an administrative penalty from the Guangdong Regulatory Bureau for false statements in its annual reports from 2018 to 2021, which establishes a basis for claims [1] Group 2: Financial Performance and Market Reaction - On April 30, 2025, the company announced abnormal stock trading fluctuations, with a cumulative decline of 8.58% over three trading days [1] - The company disclosed its 2024 annual report on the same day, with the registered accountant issuing an opinion of "unable to express an opinion," indicating concerns about the company's operational status [1]